Weight Loss Tips
Paying for Weight Loss Treatment in Instalments
A single large upfront cost is a genuine barrier for many people considering weight loss treatment. Here is how instalme...
Whether these drugs work is settled. Whether spending the money is worth it for you is a different question, and it has almost nothing to do with the trial results.
Four questions decide it. Work through them honestly before spending anything.
Question one: can you complete the course?
This is the one that matters most and gets asked least.
STEP 1 measured its results at 68 weeks, published in the New England Journal of Medicine. SURMOUNT-1 ran 72 weeks. Those figures describe continuous, uninterrupted treatment for well over a year.
GLP-1 medication manages weight while you take it. Appetite returns after stopping and weight regain is common.
So a six-month course, ended because money ran out or supply failed, buys six months of weight loss followed by regain. The money is spent and the outcome reverts.
If you cannot see a realistic path to funding and sourcing the full duration, the honest answer to this article's title is no, regardless of how good the drug is.
Question two: what are you actually buying?
People assume they are buying a number on the scale. Frequently the more valuable purchase is something else.
The SELECT trial, published in 2023, followed adults with obesity and existing cardiovascular disease but without diabetes. Semaglutide reduced major adverse cardiovascular events compared with placebo.
That matters because it reframes the value calculation. If you have obesity plus cardiovascular disease, plus prediabetes, plus sleep apnea, you are potentially buying reduced risk of serious events rather than a smaller clothing size.
Health improvements also arrive earlier than most people expect. A 5 to 10 percent reduction typically improves blood pressure, blood sugar, cholesterol and sleep apnea meaningfully. You do not need to reach a target weight to get most of the medical benefit.
Someone with a BMI of 32 and no other conditions is buying something different from someone with a BMI of 38, type 2 diabetes and hypertension. The second person's money buys considerably more.
Question three: what is the alternative use of the money?
This is where the answer is often uncomfortable.
Imported GLP-1 injections run Rs 20,000 to Rs 50,000 monthly in Pakistan, plus 20 to 40 percent in consultation, cold chain and monitoring.
Against that, consider what else that money could do.
A proper medical assessment. If hypothyroidism, PCOS, insulin resistance or a medication side effect is driving your weight, a diagnosis addresses the actual cause. This costs a fraction of a month of injections and is frequently the better purchase.
Better food. Protein is the strongest dietary lever, and eggs, dahi, daal and chana deliver it cheaply.
Orlistat, the one affordable medication with reliable local availability, producing 5.8 kg over four years.
Nothing. If you have not yet made the free changes — portion order, plate size, cutting liquid sugar, walking, sleep — spending on medication first is spending to avoid changes you will need to make anyway.
Medication is most worth it for someone who has genuinely addressed the free options and still cannot control intake because hunger overwhelms the effort.
Question four: is your problem actually hunger?
This is the diagnostic question, and it determines whether the mechanism you are buying matches the problem you have.
GLP-1 medication reduces appetite. That is what it does. If your obstacle is something else, it is the wrong purchase.
If you eat large portions and remain hungry, if food occupies your thinking, if you eat past fullness routinely, if hunger returns within an hour of eating — that is appetite signalling, and appetite is what this medication addresses.
If you know what to eat and eat reasonably but move very little, activity is the gap.
If your eating is driven by stress, boredom or emotion rather than hunger, that is a reward pathway problem, and it may need psychological support rather than appetite suppression.
If you eat sensibly and gain weight anyway, get investigated before buying anything.
A drug that reduces hunger in someone whose problem is not hunger is expensive and disappointing.
When the answer is clearly yes
- BMI 30 or above, or 27 plus a weight-related condition
- Persistent hunger that has defeated repeated genuine attempts
- Existing cardiovascular disease, type 2 diabetes, sleep apnea or fatty liver
- Ability to fund and source a full course
- Free changes already attempted seriously
For that person, this medication is among the most effective interventions in modern medicine, and the money is well spent.
When the answer is clearly no
- You cannot fund or source the full duration
- Your BMI is in the healthy range
- You have not attempted the free changes
- You want rapid loss for a specific event
- You are buying from an unverifiable source
That last point deserves emphasis. Money spent on an unverified pen from an informal seller buys an unknown substance. That is not an expensive treatment, it is a loss.
The middle case
Most people reading this are in the middle. Real weight problem, real hunger, genuinely cannot sustain Rs 20,000 to Rs 50,000 monthly for eighteen months.
The honest response is not to pretend imported injections are affordable. It is to ask what is obtainable and supervised at a cost you can actually sustain across a full course.
METASLIM™ by Lupin Life is a physician-reviewed sublingual supplement working on the GLP-1 appetite pathway, with physician review before dispatch. It is not semaglutide or tirzepatide, does not produce STEP 1 or SURMOUNT-1 results, and nobody should suggest it does.
What it addresses is question one. A course you can complete produces more retained benefit than a stronger course abandoned at month four.
Before deciding anything, check your BMI. Our cost per kilogram comparison works through the value arithmetic in detail.
The summary
The drug working and the spending being worth it are different questions.
Completion is the deciding factor. An unfinished course buys temporary loss followed by regain.
Health benefits arrive at 5 to 10 percent reduction, well before a target weight, and are worth more than the number on the scale.
If your problem is not hunger, appetite medication is the wrong purchase.
If free changes have not been attempted, medication is premature.
See if you qualify for the program once you have worked through those four questions.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.